NCT02097589View on ClinicalTrials.gov

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Controls
Interventions
DRUG

Atorvastatin

10-person arm receiving treatment for 28 days: 40 mg atorvastatin, taken orally, once daily, for 28 days.

DRUG

Pneumovax 23

Pneumovax 23 injected once, intramuscularly at Day 7.

OTHER

Placebo (lactose pill)

10-person arm receiving treatment for 28 days: Placebo (lactose pill), taken orally, once daily for 28 days.

Trial Locations (1)

32610

University of Florida Clinical Translational Research Building, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02097589 - The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23 | Biotech Hunter | Biotech Hunter